177 related articles for article (PubMed ID: 9423805)
1. A study of platelet activation during human cardiopulmonary bypass and the effect of S-nitrosoglutathione.
Langford EJ; Parfitt A; de Belder AJ; Marrinan MT; Martin JF
Thromb Haemost; 1997 Dec; 78(6):1516-9. PubMed ID: 9423805
[TBL] [Abstract][Full Text] [Related]
2. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
Chung A; Wildhirt SM; Wang S; Koshal A; Radomski MW
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Noronha-Dutra AA
Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
[TBL] [Abstract][Full Text] [Related]
4. Platelet preservation with a glycoprotein IIb/IIIa inhibitor in a porcine cardiopulmonary bypass model.
Kondo N; Suzuki Y; Wakayama F; Tamai Y; Ji K; Fukui K; Fukuda I
Ann Thorac Surg; 2005 Jul; 80(1):251-7. PubMed ID: 15975376
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty.
Langford EJ; Brown AS; Wainwright RJ; de Belder AJ; Thomas MR; Smith RE; Radomski MW; Martin JF; Moncada S
Lancet; 1994 Nov; 344(8935):1458-60. PubMed ID: 7526102
[TBL] [Abstract][Full Text] [Related]
6. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
7. Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors.
Langford EJ; Wainwright RJ; Martin JF
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):51-5. PubMed ID: 8548426
[TBL] [Abstract][Full Text] [Related]
8. Nitrosoglutathione modulation of platelet activation and nitric oxide synthase expression in promotion of flap survival after ischemia/reperfusion injury.
Kuo YR; Wang FS; Jeng SF; Huang HC; Wei FC; Yang KD
J Surg Res; 2004 Jun; 119(1):92-9. PubMed ID: 15126088
[TBL] [Abstract][Full Text] [Related]
9. S-nitrosoglutathione inhibits platelet activation and deposition in coronary artery saphenous vein grafts in vitro and in vivo.
Salas E; Langford EJ; Marrinan MT; Martin JF; Moncada S; de Belder AJ
Heart; 1998 Aug; 80(2):146-50. PubMed ID: 9813560
[TBL] [Abstract][Full Text] [Related]
10. The effects of S-nitrosoglutathione on platelet activation, hypertension, and uterine and fetal Doppler in severe preeclampsia.
Lees C; Langford E; Brown AS; de Belder A; Pickles A; Martin JF; Campbell S
Obstet Gynecol; 1996 Jul; 88(1):14-9. PubMed ID: 8684748
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation.
Kanemitsu S; Nishikawa M; Onoda K; Shimono T; Shimpo H; Yazaki A; Tanaka K; Shiku H; Yada I
J Thorac Cardiovasc Surg; 2003 Aug; 126(2):428-35. PubMed ID: 12928640
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation.
Straub A; Wendel HP; Dietz K; Schiebold D; Peter K; Schoenwaelder SM; Ziemer G
Thromb Haemost; 2008 Mar; 99(3):609-15. PubMed ID: 18327411
[TBL] [Abstract][Full Text] [Related]
13. Increased nitric oxide synthase activity after canine cardiopulmonary bypass is suppressed by s-nitrosoglutathione.
Mayers I; Salas E; Hurst T; Johnson D; Radomski MW
J Thorac Cardiovasc Surg; 1999 May; 117(5):1009-16. PubMed ID: 10220697
[TBL] [Abstract][Full Text] [Related]
14. Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets.
McKenzie ME; Malinin AI; Bell CR; Dzhanashvili A; Horowitz ED; Oshrine BR; Atar D; Serebruany VL
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):249-53. PubMed ID: 12695747
[TBL] [Abstract][Full Text] [Related]
15. Role of von Willebrand factor in tumour cell-induced platelet aggregation: differential regulation by NO and prostacyclin.
Jurasz P; Stewart MW; Radomski A; Khadour F; Duszyk M; Radomski MW
Br J Pharmacol; 2001 Nov; 134(5):1104-12. PubMed ID: 11682459
[TBL] [Abstract][Full Text] [Related]
16. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
[TBL] [Abstract][Full Text] [Related]
17. Platelet function during cardiopulmonary bypass not changed by two different doses of aprotinin.
Santamaría A; Mateo J; Muñíz-Díaz E; Oliver A; Murillo J; Litvan H; Souto JC; Fontcuberta J
Haematologica; 2000 Apr; 85(4):381-5. PubMed ID: 10756363
[TBL] [Abstract][Full Text] [Related]
18. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
[TBL] [Abstract][Full Text] [Related]
19. [Effect of danshen injection on expression of platelet membrane glycoproteins in patients with type II diabetes mellitus].
Zhang M; Li X; Jiu G; Liu Y
Zhong Yao Cai; 2003 Oct; 26(10):738-40. PubMed ID: 14768394
[TBL] [Abstract][Full Text] [Related]
20. Platelet anaesthesia during extracorporeal circulation: differential effects of GP IIb/IIIa blockers on platelet activation marker P-selectin expression at hypothermia.
Straub A; Schiebold D; Wendel HP; Azevedo R; Dietz K; Ziemer G
Thromb Res; 2008; 122(3):383-9. PubMed ID: 18304613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
